Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease.
about
Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease modelsRole of docosahexaenoic acid in the modulation of glial cells in Alzheimer's diseaseDocosahexaenoic Acid and Cognition throughout the LifespanDHA Effects in Brain Development and FunctionPeroxisomes in brain development and functionPotential Links between Impaired One-Carbon Metabolism Due to Polymorphisms, Inadequate B-Vitamin Status, and the Development of Alzheimer's DiseaseUsing neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease.A nutrient combination that can affect synapse formationMetabolomic Identification in Cerebrospinal Fluid of the Effects of High Dietary Cholesterol in a Rabbit Model of Alzheimer's DiseaseNutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementia.Neuroprotectin D1 induces neuronal survival and downregulation of amyloidogenic processing in Alzheimer's disease cellular models.Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases.Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer's disease.Serum cholesterol and variant in cholesterol-related gene CETP predict white matter microstructureFatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it contributing to higher risk of cognitive decline and coronary heart disease?Global cPILOT analysis of the APP/PS-1 mouse liver proteome.An amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer's disease.Towards a whole-body systems [multi-organ] lipidomics in Alzheimer's disease.Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA.Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease.Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease.Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.Effects of diet and behavioral enrichment on free fatty acids in the aged canine brainCurcumin boosts DHA in the brain: Implications for the prevention of anxiety disorders.Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD).Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 PhagocytosisRelationship between central and peripheral fatty acids in humansExercise facilitates the action of dietary DHA on functional recovery after brain trauma.Lipidomics of Alzheimer's disease: current status.Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.Neuroinflammation and proteostasis are modulated by endogenously biosynthesized neuroprotectin D1.The docosanoid neuroprotectin D1 induces homeostatic regulation of neuroinflammation and cell survival.Lipidomics applications in health, disease and nutrition research.Mass spectrometry strategies for clinical metabolomics and lipidomics in psychiatry, neurology, and neuro-oncology.Ageing and apoE change DHA homeostasis: relevance to age-related cognitive decline.Diet, nutrients and metabolism: cogs in the wheel driving Alzheimer's disease pathology?New Perspectives on Alzheimer's Disease and Nutrition.The blood-brain barrier fatty acid transport protein 1 (FATP1/SLC27A1) supplies docosahexaenoic acid to the brain, and insulin facilitates transport.Unbiased Metabolomic Investigation of Alzheimer's Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism.ER stress and impaired autophagy flux in neuronal degeneration and brain injury.
P2860
Q21135583-85937E65-FA20-4CA5-B6A1-11067B3B61AAQ26766462-9BDBB683-58FA-4CA1-B55E-049A0A2C0FF5Q26768442-DE936A69-DA30-41F2-BC61-166E7D00D2F0Q26770284-11C4CD23-56AE-4246-874B-E29CF6ACF9ACQ26774697-CB7873E0-8AB9-47FA-AD67-E03A56ED77A5Q28068353-44E043D5-EC50-460C-9EBA-A57EF193A321Q30451918-00064ADE-218B-4AF4-BD07-638B4CE69763Q33570506-6364E7D3-D1F0-4B6A-AD9C-18668469D3CBQ33631144-9DB30D0C-8FD3-4FAB-8A67-BBC356A39BEEQ33813927-C8898A84-A5A7-48B9-8195-3A101098D56BQ33853865-E2E08221-6093-4EEB-ACB3-DB11B354D45BQ34027672-C3E96D34-BE95-4066-BCBC-354BB4478C2AQ34064292-9BA9F471-523D-4502-B9FC-047B52C52081Q34344559-78EA2D05-7429-49B4-8A19-D97D75C74738Q34411741-E933070D-F942-4D93-A799-F0A97719CC1FQ34459615-4D27795A-E1DA-40A8-8169-234024B1E79BQ35159081-81027946-5E73-4019-9234-66FD4AEA9BB7Q35179546-47A2634B-8D77-46BF-BC0C-ECE8F1E2A6AEQ35507433-1012EAB1-883A-450C-92D3-511930CCDE67Q35677425-97753EF3-DF1D-42CB-BAD9-6A81883283CEQ35885375-F572B6E7-3C98-4CF0-AB3E-B551A4C2D906Q36121377-0B141C89-FB45-463F-9E39-B0D223FB2A75Q36249900-5E38170A-743C-456B-ABBF-37ABBB699729Q36582307-6EFE50B8-4296-4609-8485-5A8218289986Q36713818-98644138-2872-4823-81AF-6A812B240DC7Q36777563-D4726078-2CBB-4FF1-81E4-1BE36BB9DF42Q36921968-53A780CA-8899-497B-8C1E-ABC63DF29C9AQ37634130-60EDADF9-1107-4B14-853E-57E42A1A25D7Q37980283-A5D5B27D-C0E8-436D-9C8D-BA7D6A4A54EEQ37981491-C1BA2F6E-4456-4644-8D37-D74937C141B3Q38041487-7E9CAFAC-A363-4B57-BD4C-E25F94F493B7Q38047657-C20DC4CD-88E9-4340-B42E-05AC8F04D1F4Q38111301-E442535B-BF85-4CF7-A083-DA01098965B1Q38120648-3666A915-9AB1-4D71-8A4F-4B4C872DA767Q38150523-3118D110-BDD2-4942-B97C-9B33AD1AC015Q38413096-D26FE279-3F70-41A0-A20C-840732635BCFQ38592243-258CF266-631A-495F-AFF8-97A6B79A6E22Q38723657-385E816E-0735-4BCF-B9E4-3B1B4327415CQ38926696-712860E8-0D35-43A0-91A1-3DA28219F098Q38946303-83B8ED29-DF07-41BE-8DB6-2201909A5671
P2860
Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Deficient liver biosynthesis o ...... irment in Alzheimer's disease.
@ast
Deficient liver biosynthesis o ...... irment in Alzheimer's disease.
@en
type
label
Deficient liver biosynthesis o ...... irment in Alzheimer's disease.
@ast
Deficient liver biosynthesis o ...... irment in Alzheimer's disease.
@en
prefLabel
Deficient liver biosynthesis o ...... irment in Alzheimer's disease.
@ast
Deficient liver biosynthesis o ...... irment in Alzheimer's disease.
@en
P2093
P2860
P1433
P1476
Deficient liver biosynthesis o ...... airment in Alzheimer's disease
@en
P2093
Carl W Cotman
Daniel L Gillen
Daniele Piomelli
Elizabeth Head
Nicole C Berchtold
Vinh Q Nguyen
P2860
P304
P356
10.1371/JOURNAL.PONE.0012538
P407
P577
2010-09-08T00:00:00Z